86.22.Z - Specialist medical practice
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
68.20.Z - Rental and management of own or leased real estate
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.21.Z - General medical practice
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,9 | 5,6 | 3,4 | -39,8 |
EBITDA | 4,6 | 6,1 | 5,6 | -8,6 |
Short time liabilities | 0,9 | 5,7 | 2,2 | -61,9 |
Equity capital | 12,6 | 15,1 | 15,8 | 4,7 |
Operating profit (EBIT) | 3,7 | 5,2 | 3,3 | -36,1 |
Assets | 13,9 | 21,1 | 18,2 | -14 |
Net profit (loss) | 3,1 | 4,5 | 2,7 | -40,1 |
Cash | 9,3 | 10,3 | 8,1 | -20,9 |
Net income from sale | 16,8 | 20,2 | 22,5 | 11,2 |
Liabilities and provisions for liabilities | 1,4 | 6,1 | 2,4 | -60,6 |
Working assets | 11,1 | 12,2 | 10,6 | -13,2 |
Depreciation | 0,9 | 0,9 | 2,3 | 146,1 |
% | % | % | p.p. | |
Profitability of capital | 24,9 | 30 | 17,1 | -12,9 |
Equity capital to total assets | 90,2 | 71,3 | 86,9 | 15,6 |
Gross profit margin | 23 | 27,6 | 15 | -12,6 |
EBITDA Margin | 27,4 | 30,3 | 24,9 | -5,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 20 | 104 | 35 | -69 |
Current financial liquidity indicator | 8.174920082092285 | 2.0181379318237305 | 4.453799247741699 | 2,5 |
Net dept to EBITDA | -1.9989126920700073 | -1.68443763256073 | -1.255028486251831 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane